CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 156 filers reported holding CARDLYTICS INC in Q4 2019. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,125,000 | +161.1% | 250,000 | 0.0% | 0.54% | +162.0% |
Q2 2023 | $1,580,000 | +86.2% | 250,000 | 0.0% | 0.21% | +79.3% |
Q1 2023 | $848,750 | -46.8% | 250,000 | -9.4% | 0.12% | -50.4% |
Q4 2022 | $1,594,789 | +15.6% | 275,915 | +87.9% | 0.23% | +30.0% |
Q3 2022 | $1,380,000 | -40.1% | 146,851 | +42.2% | 0.18% | -42.1% |
Q2 2022 | $2,304,000 | -48.7% | 103,270 | +26.5% | 0.31% | -45.5% |
Q1 2022 | $4,488,000 | +19.6% | 81,627 | +43.7% | 0.57% | +8.1% |
Q4 2021 | $3,753,000 | -6.7% | 56,786 | +18.5% | 0.53% | -5.9% |
Q3 2021 | $4,023,000 | +14.5% | 47,930 | +73.2% | 0.56% | +30.5% |
Q2 2021 | $3,514,000 | +165.4% | 27,681 | +129.3% | 0.43% | +106.7% |
Q1 2021 | $1,324,000 | -46.2% | 12,070 | -82.8% | 0.21% | -21.2% |
Q1 2020 | $2,460,000 | -77.3% | 70,371 | -59.2% | 0.26% | -66.5% |
Q4 2019 | $10,848,000 | +74.0% | 172,581 | -7.2% | 0.79% | +71.5% |
Q3 2019 | $6,235,000 | +836.2% | 186,000 | +308.3% | 0.46% | +876.6% |
Q1 2018 | $666,000 | – | 45,557 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
Cannell Capital | 626,975 | $16,289,000 | 4.62% |
Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |